Consolidated Portfolio Review Corp’s Insulet PODD Stock Holding History

Consolidated Portfolio Review Corp’s Portfolio PODD Stock Details PODD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3,704	Closed	-$1.14M	–	300
2025 Q3	$1.14M	Sell	3,704 -44	-1%	-$13.8K	0.14%	154
2025 Q2	$1.18M	Sell	3,748 -1	-0%	-$289	0.16%	141
2025 Q1	$985K	Hold	3,749	–	–	0.16%	150
2024 Q4	$979K	Hold	3,749	–	–	0.16%	155
2024 Q3	$873K	Sell	3,749 -6	-0.2%	-$1.23K	0.19%	136
2024 Q2	$758K	Sell	3,755 -5	-0.1%	-$901	0.18%	147
2024 Q1	$644K	Buy	3,760 +47	+1%	+$8.77K	0.17%	139
2023 Q4	$806K	Buy	3,713 +57	+2%	+$9.78K	0.18%	125
2023 Q3	$583K	Sell	3,656 -16	-0.4%	-$3.58K	0.14%	155
2023 Q2	$1.06M	Buy	3,672 +16	+0.4%	+$4.86K	0.25%	104
2023 Q1	$1.17M	Buy	+3,656	New	+$1.08M	0.32%	86

Other funds holding PODD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Consolidated Portfolio Review Corp's PODD Position: Q4 2025 in Review

Consolidated Portfolio Review Corp sold out of Insulet (PODD) in Q4 2025, closing a stake of 3,704 shares — an estimated $1.14M sold.

Consolidated Portfolio Review Corp first reported a position in PODD in Q1 2023 and held it in 11 quarters. The position peaked at $1.18M in Q2 2025. 833 funds tracked by Wall St. Rank hold PODD as of Q4 2025.

Consolidated Portfolio Review Corp reported no remaining Insulet position as of Q4 2025 after selling out during the quarter.
Consolidated Portfolio Review Corp sold 3,704 Insulet shares in Q4 2025, an estimated $1.14M.
Consolidated Portfolio Review Corp first reported a position in Insulet in Q1 2023 and held it in 11 quarters.
Consolidated Portfolio Review Corp's Insulet position peaked at $1.18M in Q2 2025.
833 funds tracked by Wall St. Rank held Insulet as of Q4 2025.

Based on Consolidated Portfolio Review Corp's 13F filing for Q4 2025, filed 26 Jan 2026.